Tagged with Tamer Group

Saudi Arabia Pharma News: Riyadh Global Medical Biotech Summit Opens; COVID Measures Reduce MERS Prevalence; 194 Health Facilities Shut in 2022

Saudi Arabia Saudi Arabia Pharma News: Riyadh Global Medical Biotech Summit Opens; COVID Measures Reduce MERS Prevalence; 194 Health Facilities Shut in 2022

Saudi Arabia The latest news from the Saudi healthcare and life science industry, including how the implementation of COVID-19 measures have helped reduce the prevalence of MERS-CoV in the country, regulatory approval for Alvotech and Bioventure’s Humira biosimilar, and Open Medical’s new partnership with Tamer Group around digital transformation solutions. As…

IP in Saudi Arabia: Room for Improvement?

Saudi Arabia IP in Saudi Arabia: Room for Improvement?

Saudi Arabia While Saudi Arabia is becoming an increasingly attractive investment destination for global pharma, some stakeholders continue to have concerns about whether the country’s intellectual property (IP) protection system is truly fit for purpose. Oscar Delgado of BMS is one such stakeholder. “An adequate IP system, including regulatory data protection…

Four Key Trends in Saudi Pharma Distribution

Saudi Arabia Four Key Trends in Saudi Pharma Distribution

Saudi Arabia As the Saudi pharma market – worth approximately USD 8.2 billion – continues to grow, so does the need for pharma companies to efficiently distribute their medicines inside the Kingdom. Here, we present four of the main trends at play in the Saudi distribution landscape, from market consolidation to centralised…

Fayad Al Dandashi – CEO, Tamer HealthCare

Saudi Arabia Fayad Al Dandashi – CEO, Tamer HealthCare

Saudi Arabia Dr Fayad Al Dandashi, CEO of Tamer HealthCare, a leading Saudi healthcare company, discusses how the group aims to benefit from Saudi Arabia’s healthcare transformation through digitalization, changing their product-oriented business model to a holistic service-driven business model. After years of entrepreneurial and public sector experience, he explains the changes…

Ayman Tamer – Chairman & Managing Partner, Tamer Group

Saudi Arabia Ayman Tamer – Chairman & Managing Partner, Tamer Group

Saudi Arabia Aymen Tamer, chairman and managing partner of historic Saudi healthcare firm Tamer Group, outlines how, informed by Saudi’s Vision 2030, the company is adapting to better meet the needs of the rapidly evolving domestic pharma market. Tamer also touches on the challenges of succession planning, why a deep and long-term…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page